Companies / IN8bio, Inc.

IN8bio, Inc.

Nasdaq: INABCIK 1740279NEW YORK, NY

Financials

Revenue
Net income$-19.44M
Total debt
Cash
Diluted EPS$-4.44
Shares outstanding9.9M

Ownership

9.9M shares outstanding · as of Aug 3, 2026
19.1%10%+ / strategic
Ownership
10%+ / strategic19.08%1,880,912
Institutions14.42%1,421,634
Public float66.50%6,555,837

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Ho William Tai-WeiCEOCEO · Director · 10% owner
Lamb LawrenceFormerEVP and CSO
McCall PatrickCHIEF FINANCIAL OFFICER
Rochlin KatePresident and COO

Institutional holders 22

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$96.6K+65K
+311.27%
86,239
0.87% of shares
low
Q1 2026
as of
Two Sigma Investments, LP
13F manager
ExitCommon Stock$-66.0K-28K
-100.00%
0
low
Q2 2026
as of
Texas Capital Bank Wealth Management Services Inc
13F manager
AddCommon Stock$925+656
+2.76%
24,406
0.25% of shares
low
Q4 2025
as of
Bank of America Corp /De
13F manager
AddCommon Stock$2+1
+2.78%
37
<0.01% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Lytton Laurence WPassive13G
Alyeska Investment Group, L.P.Passive13G966,381
Franklin Resources, Inc.Passive13G914,531

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
INABCommon StockEquity45674E208BBG00XX9K1M2